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The formation of intricately organized aortic and pulmonic valves from primitive endocardial cushions of
the outﬂow tract is a remarkable accomplishment of embryonic development. While not always initially
pathologic, developmental semilunar valve (SLV) defects, including bicuspid aortic valve, frequently
progress to a disease state in adults requiring valve replacement surgery. Disrupted embryonic growth,
differentiation, and patterning events that “trigger” SLV disease are coordinated by gene expression
changes in endocardial, myocardial, and cushion mesenchymal cells. We explored roles of chromatin
regulation in valve gene regulatory networks by conditional inactivation of the Brg1-associated factor
(BAF) chromatin remodeling complex in the endocardial lineage. Endocardial Brg1-deﬁcient mouse
embryos develop thickened and disorganized SLV cusps that frequently become bicuspid and myx-
omatous, including in surviving adults. These SLV disease-like phenotypes originate from deﬁcient en-
docardial-to-mesenchymal transformation (EMT) in the proximal outﬂow tract (pOFT) cushions. The
missing cells are replaced by compensating neural crest or other non-EMT-derived mesenchyme.
However, these cells are incompetent to fully pattern the valve interstitium into distinct regions with
specialized extracellular matrices. Transcriptomics reveal genes that may promote growth and patterning
of SLVs and/or serve as disease-state biomarkers. Mechanistic studies of SLV disease genes should dis-
tinguish between disease origins and progression; the latter may reﬂect secondary responses to a dis-
rupted developmental system.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Congenital valve defects affect at least 2% of humans, a remarkable
frequency that underlines the urgent need to understand their etiol-
ogy (Hoffman and Kaplan, 2002; Siu and Silversides, 2010; Go et al.,
2013). Frequently, developmentally abnormal valves do not progress to
a pathologic state until late adulthood. For example, many cases of
adult aortic valve disease characterized by thickened and myxomatous
valve cusps display bicuspid rather than tricuspid arrangements ori-
ginating from fusions during development (Angelini et al., 1989; Ro-
berts and Ko, 2005). The rationale design of diagnostics and ther-
apeutics therefore must distinguish between disrupted developmental
processes, and their genetic and environmental inﬂuences, that trigger
valve defects from mechanisms that drive the progression of an ana-
tomically abnormal valve to a disease state.ology, Department of Biology,
lin Blvd, Eugene, OR 97403-
.Valvulogenesis is a dynamic and multistep process that trans-
forms primitive endocardial cushions (ECs) into highly patterned
valves with thin, elongated leaﬂets or cusps. ECs form at discrete
sites of the looping heart tube by the local secretion of a specia-
lized extracellular matrix called the cardiac jelly. The mesenchyme
of atrioventricular canal ECs, which generate the mitral and tri-
cuspid valves, originates from an endothelial-to-mesenchymal
transition (EMT) of a subset of overlying endocardial cells. The
outﬂow tract contains two pairs of neighboring ECs that together
will form the semilunar valves. The proximal outﬂow tract (pOFT)
cushions are primarily populated by EMT-derived mesenchyme. In
contrast, the distal outﬂow tract (dOFT) cushion mesenchyme is
largely derived from invading cardiac neural crest cells (NCCs)
(Kirby et al., 1983; Waldo et al., 1998; Jiang et al., 2000). Additional
cell populations, possibly of second heart ﬁeld (SHF) origin, may
contribute additional mesenchyme to the OFT cushions (Engleka
et al., 2012; Sizarov et al., 2012).
EMT begins at embryonic day 9.5 (E9.5) in the AVC and soon
after in the pOFT (Camenisch et al., 2002). Signaling factors, no-
tably TGF-beta superfamily and Notch proteins, direct EMT by
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docardial cells from an interconnected epithelial to invasive me-
senchymal state (Ramsdell and Markwald, 1997; Timmerman
et al., 2004; Fischer et al., 2007; Venkatesh et al., 2008; Luna-
Zurita et al., 2010; Chang et al., 2011; Wang et al., 2013). Deﬁcient
mesenchyme production, including when EMT is disrupted, im-
pedes subsequent steps of valve development and leads to con-
genitally abnormal valves. A connection between EMT disruption
and semilunar valve disease is suggested by Notch1 being one of
the few identiﬁed human aortic valve disease genes (Garg et al.,
2005), although Notch signaling may also have later roles in valve
development or homeostasis (Hofmann et al., 2012; Theodoris
et al., 2015).
After EMT, the paired OFT ECs undergo a complex rearrange-
ment to form two sets of symmetric tricuspid semilunar valves. By
E13.5, the ECs meet and rearrange concomitantly with OFT sep-
tation to form separate pulmonic and aortic valves. The three
cusps of each semilunar valve elongate and reﬁne into thin tissues
that will distend to meet and form a tight seal but have the ﬂex-
ibility to promptly open under pressure. Through postnatal de-
velopment, the valve interstitium becomes stratiﬁed into layers of
distinct extracellular matrix (ECM) composition to confer appro-
priate stiffness/ﬂexibility across the cusps' short axis (Gross and
Kugel, 1931; Broom, 1978; Hinton et al., 2006). Genetic loss or
disruption of several extracellular proteins, such as Versican
(Vcan) and Periostin (Postn), or their regulators, notably Adamts-
family matrix proteases, produce valve defects (Tkatchenko et al.,
2009; Kern et al., 2010; Dupuis et al., 2011; Cheek et al., 2012).
The semilunar valves are also patterned along their proximal-
to-distal (long) axis. Each cusp of both aortic and pulmonic valves
can be considered as a shallow bisected cup fastened within a
cylindrical structure (Fig. S1A–C). The cusps' base region that
connects them to underlying muscle is enriched with Tenascin C
(Tnc), which helps confer tissue rigidity (Zhang et al., 1993; Satta
et al., 2002; Hinton et al., 2006). In contrast, the distal part of each
cusp expresses high levels of Vcan and Postn (Kruzynska-Frejtag
et al., 2001; Norris et al., 2008; Snider et al., 2008; Kern et al.,
2010). The junction between the stiff base and ﬂexible distal re-
gions is commonly termed the hinge. The multi-dimensional or-
ganization of semilunar valve interstitium suggests that valve
patterning requires a highly coordinated series of events that act
over an extended period of development. Any of these steps could
be perturbed to cause formation of a congenitally abnormal valve.
Human genetics and model organism studies, largely in mice,
highlight disrupted regulatory pathways that coalesce on tran-
scriptional changes as primary sources of SLV defects. For example,
disrupted Notch signaling produces bicuspid aortic valve (BAV) in
both mice and humans (Garg et al., 2005; Jain et al., 2011; Bosse
et al., 2013). Additional mouse models of semilunar valve disease
implicate Gata5 and Pax3 transcription factors and transcriptional
effectors of Tgf-β family signaling (Jain et al., 2011; Laforest et al.,
2011; Thomas et al., 2012; Dupuis et al., 2013). The molecular ac-
tivities of these transcription factors, including an understanding
of how they function within a chromatinized landscape to direct
speciﬁc responses, are poorly understood. A role for chromatin
regulation in human SLV disease is supported by the high fre-
quency of de novo variants in histone modifying genes in con-
genital heart disease (Zaidi et al., 2013). Further the sporadic in-
heritance patterns in afﬂicted families (Clementi et al., 1996;
Huntington et al., 1997) suggest epigenetic inﬂuences that modify
penetrance and/or expressivity of disease-causing alleles.
The Brg1-associated factor (BAF) chromatin remodeling com-
plex facilitates activation and repression of genes by ATP-depen-
dent nucleosome repositioning and/or replacement. The core AT-
Pase subunit is predominantly provided by Brg1; in most cases,
loss of Brg1 alone inactivates the BAF complex (Kadoch andCrabtree, 2013). Coordinately, Brg1-null mice are peri-implanta-
tion lethal (Bultman et al., 2000). The BAF complex has been im-
plicated in multiple steps of heart development and disease, in-
cluding cardiac speciﬁcation and hypertrophy (Lickert et al., 2004;
Hang et al., 2010; Takeuchi et al., 2011). Further, Brg1 is required in
endocardial cells to maintain the microenvironment required for
the initiation of cardiac trabeculation (Stankunas et al., 2008). Brg1
expression in endocardial and mesenchymal cells of the develop-
ing valves suggests additional roles for endocardial lineage BAF
complexes during valvulogenesis.
Here, we disrupt endocardial-lineage Brg1 in mice to demon-
strate that the BAF chromatin remodeling complex is essential for
semilunar valve development. Endocardial Brg1-deﬁcient embryos
develop thickened aortic and pulmonic valves that frequently are
bicuspid and progress to a myxomatous, disease-like state. We
map the origins of these defects to a partial disruption of pOFT
EMT, a process an earlier deletion of endocardial Brg1 shows the
BAF complex is required for in both the pOFT and AVC. Developing
semilunar valves compensate for the deﬁciency of EMT-derived
mesenchyme but the responding mesenchymal populations are
insufﬁcient to fully pattern a complex, multi-origin semilunar
valve interstitium. Therefore, an initial deﬁciency of pOFT EMT can
trigger secondary responses that culminate in semilunar valve
disease. By RNA-seq analysis of the Brg1-deﬁcient valves, we ad-
ditionally identify and characterize the expression of novel tran-
scripts that may promote growth and patterning of semilunar
valves and/or serve as biomarkers of a diseased state.2. Materials and methods
2.1. Mice
All mouse husbandry and procedures were approved and
monitored by the University of Oregon's Institutional Animal Care
and Use Committee. Transgenic lines are described in Supple-
mental materials.
2.2. Tissue processing and sectioning
Mouse embryos or dissected adult hearts were ﬁxed overnight in
4% PFA/PBS at 4 °C. Fixed tissue was washed thoroughly and then
equilibrated overnight with PBS at 4 °C. Samples were dehydrated
through a graded ethanol series and cleared with xylenes prior to
parafﬁn embedding. 7 μm parafﬁn sections were transferred to mi-
croscope slides for either histological or ﬂuorescent antibody staining.
Cryosections were used for RNA in situ hybridizations and occasional
antibody staining (see Supplemental materials). For cryosections,
embryos were ﬁxed as described, washed thoroughly with PBS,
equilibrated in 30% sucrose overnight at 4 °C, embedded in OCT (Tis-
sue-Tek), and sectioned (16 μm).
2.3. Histology
Hematoxylin and eosin (H&E) staining used parafﬁn sections
and conventional reagents and methodology (Ricca Chemical
Company). Masson's Trichrome staining on parafﬁn sections used
a reagent kit following manufacturer's instructions (Electron Mi-
croscopy Sciences). Von Kossa stained parafﬁn sections were
counterstained with Alcian Blue (pH 2.5) and Nuclear Fast Red
(Vector Laboratories).
2.4. Immunostaining
Parafﬁn-sectioned tissue on slides was de-parafﬁnized and re-
hydrated to distilled water using a graded series of ethanol
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mental materials. The slides were blocked with M.O.M protein
diluent (Vector Laboratories) or 10% normal goat serum (NGS) in
PBS for 1 h at RT and then stained overnight with primary anti-
bodies diluted in blocking buffer (sources and dilutions in Sup-
plemental materials). Alexa dye-conjugated ﬂuorescent secondary
antibodies (Life Technologies) were used to detect signal. Nuclei
were stained with Hoechst (Life Technologies). Slides were
mounted with Vectashield (Vector Laboratories). Immuno-
ﬂuorescent images were acquired using a wideﬁeld microscope or
an Olympus FV1000 laser-scanning confocal microscope. Confocal
images shown are average intensity projections of image stacks.
2.5. RNA in situ hybridization
In situ hybridizations were performed using cryosections
(16 μm) except for Nptx1, which used parafﬁn sections (7 μm), as
described (Stewart et al., 2014). Brieﬂy, frozen sections were wa-
shed with PBS and PBST prior to Proteinase K treatment. Alter-
natively, parafﬁn sectioned tissue was ﬁrst de-parafﬁnized and
rehydrated. Sections were post-ﬁxed with 4% PFA, washed, and
incubated with pre-hybridization buffer at 65 °C for 4 h. Digox-
igenin (DIG)-labeled RNA probes (see Supplemental materials)
were hybridized overnight at 65 °C. Following multiple washes,
the tissue was blocked with 1% Roche blocking buffer (Roche) and
then stained with alkaline phosphatase-conjugated anti-DIG an-
tibody (Roche) overnight at 4 °C. The signal was developed after
extensive TBST washes using BCIP/NBT (Promega). Tissue was
counterstained with Nuclear Fast Red (Vector Laboratories) before
being processed for mounting with Permount (Electron Micro-
scopy Sciences).
2.6. Valve morphometrics
Optimally matched H&E stained sections for each studied valve
of wildtype and littermate Nfatc1Cre;Brg1F/F embryos were imaged
for area and distance measurements using ImageJ (NIH). Length-
to-width ratios were determined as described previously (Stan-
kunas et al., 2010). Cell numbers were counted manually. Data
from multiple litters was combined by normalizing values to the
mean of wildtype embryos within each letter. Statistical sig-
niﬁcance was determined using two-tailed Student's t-tests.
2.7. Valve 3D reconstructions
7 μm serial parafﬁn sections covering the entire E16.5 aortic
valve were collected, H&E stained and imaged. All images (slices in
stack) were imported into ImageJ (NIH) and aligned manually to
neighboring valve sections using the Trakem2 plugin (Cardona
et al., 2012). An “area list” for each cusp (LCC, RCC, NCC) was
generated manually for every layer before being merged across
layers to establish 3-D shapes. Adjustments made for the z-space
and thickness were standardized for a given litter to allow a direct
comparison betweenwildtype and Nfatc1Cre;Brg1F/F aortic valves. A
two-tailed Student's t-test comparing total aortic valve volumes
(all cusps) between wildtype and Nfatc1Cre;Brg1F/F embryos used
data normalized to the mean of the wildtype aortic valve volumes
within each litter.
2.8. In vivo EdU labeling and proliferation assays
Pregnant females were IP injected with 50 mg/kg of 5-ethynyl–
2′-deoxyuridine (EdU; Life Technologies) 2–3 h before embryos
were harvested. Parafﬁn sections were prepared for staining as
described. For combined lineage tracing and EdU proliferation
studies, slides were incubated for 10′ in a pressure cooker withDAKO antigen retrieval solution (DAKO). The slides were blocked
for one hour with 10% NGS/PBS after antigen retrieval followed by
a Click-iT reaction (Life Technologies). Subsequently, slides were
washed 610′ with PBS before proceeding with anti-GFP anti-
body staining as described in the Supplemental materials.
2.9. EMT explant assays
Collagen gel EMT explant assays using dissected E10.0 outﬂow
tract tissue were performed as described (Xiong et al. 2011). 1 mg/
ml rat tail collagen I (BD Biosciences) matrices were supplemented
with 5 μg/ml doxycycline to induce the TRE:H2B-GFP reporter used
for ﬂuorescent lineage tracing. Explants were incubated at 37 °C in
5% O2/5% CO2 for 48 h before brightﬁeld and ﬂuorescent imaging
on an inverted Nikon Eclipse Ti wideﬁeld microscope.
2.10. Quantitative RT-PCR
qRT-PCR was performed using KAPA SYBR FAST qPCR Master
Mix (Kapa Biosystems) and cDNA synthesized using SuperScript III
(Life Technologies) from Trizol-isolated RNA prepared from dis-
sected valve regions. Relative mRNA expression was normalized
using a control transcript (HPRT) to calculate ΔCTs (threshold cy-
cles). Expression levels between wildtype and Nfatc1Cre;Brg1F/F
hearts were compared using a ΔΔCT approach. ΔCT values were
used for two-tailed Student's t-tests with a Bonferroni correction
for multiple comparisons to determine statistical signiﬁcance.
Primer sequences are in Supplemental materials.
2.11. Illumina RNA sequencing
The valve-containing region of E14.5 hearts was dissected un-
der a ﬂuorescent stereomicroscope using the guide of an en-
docardial-lineage nuclear GFP reporter (see Supplemental mate-
rials). RNA was extracted using TRIzol (Life Technologies). RNA-
sequencing libraries were prepared from two sets of individual
paired control and littermate Nfatc1Cre;Brg1F/F embryos as de-
scribed in Supplemental materials. The bioinformatics workﬂow to
determine differentially gene expression is also presented therein.3. Results
3.1. Endocardial Brg1 is required for semilunar valve development
Prior studies of Brg1 roles in the developing endocardium
showed that the BAF complex is required at embryonic day E9.5 to
transcriptionally maintain a microenvironment that supports
ventricular trabeculation (Stankunas et al., 2008). Persistent en-
docardial Brg1 expression throughout the embryonic heart sug-
gested additional endocardial BAF complex functions in other
heart regions or during later steps of cardiogenesis. The previous
use of the Tie2:Cre line to conditionally delete ﬂoxed Brg1 alleles
precluded studying later roles due to lethality arising from
hematopoietic and yolk sac vasculature defects in Tie2:Cre;Brg1F/F
embryos (Stankunas et al., 2008). Therefore, we used the Nfatc1Cre
line that expresses Cre from the Nfatc1 locus to speciﬁcally remove
Brg1 from endocardial but not endothelial or hematopoietic cells
(Wu et al., 2012).
Nfatc1Cre;Brg1F/F mice rarely survived to adulthood, accounting
for 3% rather than an expected 25% of animals generated from
Nfatc1Cre;Brg1F/þ X Brg1F/F intercrosses (Fig. S2A and F). A de-
creased fraction of viable Nfatc1Cre;Brg1F/F embryos was ﬁrst ob-
served at E16.5 with few animals surviving after birth, demon-
strating late embryonic or perinatal lethality. Hearts from the rare
viable postnatal day 0 (P0) Nfatc1Cre;Brg1F/F were grossly larger
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reﬂecting endocardial BAF complex roles in trabecular develop-
ment (Fig. S2B–E). The coronary artery network was reduced (Fig.
S2G–J), consistent with known BAF complex functions in vascu-
logenesis (Grifﬁn et al., 2008; Stankunas et al., 2008) and Nfatc1Cre-
driven recombination in coronary vessel endothelium of en-
docardial origin (Wu et al., 2012). These defects likely contributed
to the perinatal lethality. In addition to these phenotypes, hearts
from Nfatc1Cre;Brg1F/F newborn mice had histologically thickened
aortic and pulmonic valves (Fig. S2K–P).
We examined if the semilunar valve defects seen in Nfatc1Cre;Brg1F/
Fmice manifested earlier in development by H&E staining of sectioned
E16.5 embryos. The semilunar valve cusps of Nfatc1Cre;Brg1F/F embryos
were strikingly thickened and poorly elongated. The thinner “hinge”
region that demarcates the boundary between the distal and basal
regions of each cusp of both aortic and pulmonic valves was absent
(Fig. 1A and B; D and E). In contrast, the mitral valve of Nfatc1Cre;Brg1F/F
embryos was of normal size and organization (Fig. 1C and F). Quan-
titatively, the left and right cusps of the pulmonic valve from Nfatc1Cre;
Brg1F/F E16.5 embryos had signiﬁcantly decreased length:width ratiosFig. 1. Endocardial-lineage Brg1-deﬁcient embryos exhibit semilunar valve defects.
(A–F) Hematoxylin and eosin (H&E) stained sections from E16.5 wildtype and Nfatc1Cre;Br
the semilunar valves. (G and H) Morphometric analyzes of pulmonic and mitral valves
valve, with values normalized to the mean of the wildtype samples from individual litter
and J) 3-dimensional rendering of serial sections of aortic valves from E16.5 wildtype an
mesenchymal cell count; NS: not statistically signiﬁcant; LCC (blue): left coronary cusp; N
bicuspid fusion between left and non-coronary cusps. Scale bars: 100 μm.(0.998 vs. 0.581, Po1.0E-4), were increased in area (0.998 vs. 1.76,
Po6.0E-3), and had a concordant modest increase in the number of
interstitial cells per valve section (Po2.0E-3) (Fig. 1G). Semilunar valve
defects in Nfatc1Cre;Brg1F/F embryos ﬁrst became apparent at E14.5 as a
decreased length:width ratio of the forming cusps although without a
change in sectional area (Fig. S3B and F). E14.5 Nfatc1Cre;Brg1F/F em-
bryos also occasionally had a small membranous ventricular septal
defect, which usually resolved by E16.5 in surviving embryos (490%,
n¼ 11) (Fig. S3J–M). E16.5 Nfatc1Cre;Brg1F/F mitral valve leaﬂets ex-
hibited no signiﬁcant change in morphology or cell number (Fig. 1H),
even though many mitral valve endocardial and mesenchymal cells
had lost Brg1 protein by E14.5 (Fig. S4A–F). The divergent effects on
semilunar vs. atrioventricular canal valves suggested that the BAF
complex has a unique role during semilunar valve development or
that the idiosyncrasies of Nfatc1Cre deletion kinetics only perturbed
Brg1's role in a common process in the developing outﬂow tract.
3-D reconstruction of serial sections through the entire aortic
valve of E16.5 Nfatc1Cre;Brg1F/F and littermate embryos revealed
that Nfatc1Cre;Brg1F/F aortic valves lacked the typical thin elongated
cusps and extended aortic sinuses of wildtype littermates (Fig.g1F/F embryos showing indicated valves. Arrowheads mark the basal cusp regions of
from E16.5 wildtype and Nfatc1Cre;Brg1F/F embryos. Each data point represents one
s. Asterisks indicate a signiﬁcant difference (Po0.05, Student's two-tailed t-tests). (I
d Nfatc1Cre;Brg1F/F littermate embryos. AoV: aortic valve; L/W: length-to-width; CC:
CC (red): non-coronary cusp; RCC (yellow): right coronary cusp; LCC–NCC (purple):
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ostia with normal origins of the coronary arteries (Fig. S5E and F).
Three of the six 3-D reconstructed Nfatc1Cre;Brg1F/F aortic valves
were bicuspid. In each case, the bicuspid valve originated from a
fusion between the left and non-coronary cusps (LCC–NCC), with
residual individual cusp attachment points to the surrounding
muscle. While several Nfatc1Cre;Brg1F/F aortic valves had larger
volumes than those of paired littermates, this change was not
statistically signiﬁcant (Fig. S5G–R). Therefore, area changes seen
by sectional analysis likely represented the bulbous shape of the
valves rather than increased size, additionally highlighting how
2-D morphometric analyzes of valve development can be mis-
leading. Consistent with the valves having a normal volume, the
pulmonic valve mesenchyme of E14.5/E15.5 Nfatc1Cre;Brg1F/F mice
had no change in overall proliferation (measured by EdU in-
corporation and phospho-histone H3 staining, Fig. S6A–D, I and J)
or apoptosis (measured by TUNEL and anti-cleaved caspase 3, Fig.
S6E–H and K). Collectively, these results suggested that the
semilunar valve defects in Nfatc1Cre;Brg1F/F mice primarily re-
present a patterning/morphogenesis defect rather than overall
misregulated growth.
3.2. Bicuspid aortic valve (BAV) disease in endocardial Brg1 deﬁcient
mice
The semilunar valve (SLV) defects present at E16.5 indicated that
Nfatc1Cre;Brg1F/F mice would provide a mouse model of adult semi-
lunar valve disease if not for the predominant perinatal lethality.Fig. 2. Endocardial-lineage Brg1 deﬁcient adult mice develop aortic valve disease.
(A) Fraction of adult Nfatc1Cre-PGK;Brg1F/F or Nfatc1Cre;Brg1F/F mice with (1) thickened/m
abnormal aortic valves. (B and C) Whole mount anterior view of hearts from one yea
wildtype (D and E) and Nfatc1Cre-PGK;Brg1F/F (F and G) aortic valve sections. (H–K) Adult a
blue). Wildtype (H and I) and Nfatc1Cre;Brg1F/F (J, K) samples are shown. Black arrows m
Nuclear Fast Red) stained tissue sections from wildtype (L, M) and Nfatc1Cre;Brg1F/F (N an
coronary cusp; NCC: non-coronary cusp; RCC: right coronary cusp; LCC/RCC–NCC: bicusTherefore, we conditionally deleted Brg1 with the less efﬁcient parent
line, Nfatc1Cre-PGK, that retains the hygromycin-resistance cassette used
for gene targeting (Wu et al., 2012). As described, the majority of
Nfatc1Cre-PGK;Brg1F/F mice survived to adulthood, gradually losing their
hair and whiskers due to a failure of hair follicle stem cell renewal
(Xiong et al. 2013). While most Nfatc1Cre-PGK;Brg1F/F mice had a normal
lifespan (monitored for up to two years), their hearts were frequently
enlarged with thickened ventricles (Fig. 2B and C; Fig. S7A–D). This
cardiomyopathy could represent cardiac hypertrophy arising from
pressure overload caused by a partial outﬂow tract obstruction. We
examined hearts from adult Nfatc1Cre-PGK;Brg1F/F mice for semilunar
valve defects (Fig. 2D–G) and found that Nfatc1Cre-PGK;Brg1F/F adult mice
frequently had substantially thickened aortic valve cusps (21/26; 0/26
control littermates were affected). Nine had a bicuspid aortic valve (six
LCC–NCC and three RCC–NCC), recapitulating the E16.5 Nfatc1Cre;Brg1F/
F embryonic phenotype. The pulmonic valves were similarly thickened,
while the mitral valve appeared qualitatively normal (Fig. S7E–H).
Trichrome staining indicated that Nfatc1Cre-PGK;Brg1F/F and rare
surviving Nfatc1Cre;Brg1F/F mice aortic valves had myxomatous char-
acteristics, with extensive proteoglycan-rich material throughout the
valve and intermittent and dispersed collagen deposits rather than the
typical enrichment of collagen along the arterial side of the cusps. Ir-
regular chondrocyte-like cells with large nuclei and scattered small-
nucleated cells were present, especially at the lateral edges of the cusps
where they contact neighboring muscle (Fig. 2H–K). Similar histologic
abnormalities are seen in human aortic valve disease and additional
mouse models (Satta et al., 2002; Jackson et al., 2003; Kern et al., 2010;
Cheek et al., 2012; Hofmann et al., 2012; Krishnamurthy et al., 2012).yxomatous and/or (2) bicuspid aortic valve. 0/26 littermate control animals had
r old (1yo) wildtype and Nfatc1Cre-PGK;Brg1F/F littermate mice. (D–G) H&E stained
ortic valve sections stained using Masson's Trichrome stain (collagen deposition in
ark mislocalized collagen. (L–O) Von Kossa and Alcian Blue (counterstained with
d O) adult aortic valves. Black arrowheads indicate cartilaginous nodules. LCC: left
pid fusion between left/right and non-coronary cusps. Scale bars: 100 μm.
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disease, using Von Kossa staining. Unexpectedly, we observed little or
no change in calciﬁcation in adult Nfatc1Cre;Brg1F/F aortic valves irre-
spective of age or severity of the valve thickening/disorganization
phenotype (Fig. 2L-O). Collectively, Nfatc1Cre-PGK;Brg1F/F and rare sur-
viving Nfatc1Cre;Brg1F/F mice establish a unique model of aortic valve
disease that (1) has thickened, misorganized and myxomatous cusps,
(2) forms bicuspid arrangements usually arising from LCC–NCC fusionsFig. 3. Altered localization and levels of extracellular matrix proteins in Nfatc1Cre;Brg1F/
(A–H) Wideﬁeld ﬂuorescence images of anti-Versican (Vcan) antibody stained sections of
cryosections of E16.5 wildtype and Nfatc1Cre;Brg1F/F semilunar valves ﬂuorescently immu
and Brg1-deﬁcient valves). Pulmonic (PV) or aortic (AoV) valves are shown as indicated
nuclei are blue. White arrowheads mark areas of normal protein expression. Yellow a
decreased (Tnc) levels. Scale bars: 100 μm.and (3) does not become overtly calciﬁed.3.3. Endocardial Brg1 deﬁcient semilunar valves exhibit a loss of
interstitial organization
We explored whether the ECM defects seen in adult Nfatc1Cre-
PGK;Brg1F/F adult mice manifested developmentally or reﬂected
disease-like progression by antibody staining for ECM proteinsF semilunar valves.
E16.5 wildtype and Nfatc1Cre;Brg1F/F embryos. (I–P) Representative confocal imaged
nostained for Periostin (Postn) (I–L) or Tenascin C (Tnc) (M–P) (n¼3, paired control
. ECM proteins are shown in green/gray scale (A–D) or cyan (I–P). Hoechst-stained
rrowheads show regions with broadened (Vcan), broadened/increased (Postn) or
Fig. 4. Disorganized extracellular matrix in endocardial Brg1-deﬁcient semilunar valves reﬂects an altered organization of distinct mesenchymal lineages.
Immunoﬂuorescence images of E16.5 control (Nfatc1Cre;Brg1F/þ;R26RmTmG) or endocardial Brg1-deﬁcient (Nfatc1Cre;Brg1F/F;R26RmTmG) embryo sections simultaneously stained for GFP to
monitor Nfatc1Cre-lineage cells and either Tenascin C (Tnc) (A–F) or Periostin (Postn) (G–J). Pulmonic valves (A–D, G–J) and mitral valves (E–F) are shown. All panels are confocal images
except (E–F), which arewideﬁeld images. Overlay images show Tnc or Postn in red, GFP indicating Nfatc1Cre-lineage cells in green, and Hoechst-stained nuclei in blue. Magniﬁed regions
are outlined in dashed boxes. White arrowheads denote normal ECM localization and yellow arrowheads represent either deﬁcient (Tnc) or ectopic (Postn) ECM protein. Scale bars:
100 μm.
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B.N. Akerberg et al. / Developmental Biology 407 (2015) 158–172 165expressed in developing valves. Vcan, which is essential for valve
maturation and enriched in the medial-distal region of semilunar
valve cusps (Kern et al., 2010; Dupuis et al., 2011), became diffusely
localized in E16.5 Nfatc1Cre;Brg1F/F embryos with expression ex-
tending into the base regions (Fig. 3A–H). Postn expression, an-
other ECM protein essential for valve maturation (Norris et al.,
2008; Snider et al., 2008), was both expanded and increased in
Nfatc1Cre;Brg1F/F semilunar valve cusps (Fig. 3I–L). In contrast to
Vcan and Postn, Tnc was concentrated on the ventricular side and
towards the base of wildtype E16.5 semilunar valve cusps (Fig. 3M
and O) (Lincoln et al., 2004; Hinton et al., 2006). Reduced Tnc
expression in Nfatc1Cre;Brg1F/F embryos was especially apparent in
the left cusps of both aortic and pulmonic valves (Fig. 3N and P),
correlating with the sites of elevated Postn. Together, the mis-
localized ECM indicates a loss of patterning of the semilunar valve
cusps into distinct base and distal regions in Nfatc1Cre;Brg1F/F
embryos. Mechanistically, the disrupted ECM pattern could reﬂect
the misexpression of locally restricted ECM or ECM-modifying
transcripts and/or altered organization of distinct valve interstitial
cell populations.
3.4. Nfatc1Cre;Brg1F/F semilunar valves have reduced endocardial-
derived mesenchyme
Semilunar valve mesenchyme is derived from endocardial,
neural crest, and possibly additional lineages that have incon-
sistently been reported to populate different regions of semilunar
valve cusps (Jiang et al., 2000; de Lange et al., 2004; Nakamura
et al., 2006; Ma et al., 2008; Jain et al., 2011; Engleka et al., 2012;
Phillips et al., 2013). To explore if the aberrant ECM pattern in
Nfatc1Cre;Brg1F/F embryos reﬂected misorganization of distinct
mesenchymal sub-populations, we fate mapped endocardial cells
and their mesenchymal derivatives in Nfatc1Cre;Brg1F/F hearts
using the Rosa26RmTmG Cre reporter line (Muzumdar et al., 2007)
while double-staining for Tnc and Postn. In E16.5 wildtype em-
bryos, EMT-derived cells were scattered throughout the right and
left pulmonic valve cusps but were enriched towards the Tnc-rich
base of the cusp (Fig. 4A and B). In Nfatc1Cre;Brg1F/F embryos, EMT-
derived cells were reduced, likely accounting for the loss of the
Tnc-high ﬁeld seen in the base of the left semilunar valve cusps
(Fig. 4C and D). The mitral valves of Nfatc1Cre;Brg1F/F embryos had
normal Tnc expression in spite of substantial loss of Brg1 protein
in mitral valve mesenchyme (Figs. 4E and F and S4C and F).
Therefore, the decreased Tnc in Nfatc1Cre;Brg1F/F semilunar valve
cusps likely reﬂected depleted EMT-derived mesenchyme rather
than BAF-dependent control of Tnc expression. The high Postn-
expressing areas in the pulmonic valve cusps of Nfatc1Cre;Brg1F/F
embryos were largely populated by non-labeled cells (Fig. 4G–J).
Therefore, the increased Postn originated from a non-cell-auton-
omous response to endocardial-lineage Brg1 deletion. These re-
sults further indicate that, at least for the left cusps, specialized
EMT-derived mesenchyme produces the concentrated Tnc in the
base of the semilunar valves. The depletion of these cells upon loss
of endocardial-lineage Brg1 accounts for the bulbous valves that
lack robust basal cusp regions and therefore fail to restrain Postn-
expressing cells to the distal cusp.
We quantitatively assessed the depletion of EMT-derived
semilunar valve mesenchyme upon endocardial Brg1 deletion by
scoring the fraction of GFP-labeled pulmonic valve mesenchymal
cells in Nfatc1Cre;Brg1F/F;Rosa26RmTmG embryos (Fig. 5A and B). At
E16.5, there was a signiﬁcant decrease in the number of Nfatc1Cre-
derived mesenchymal cells in both left and right pulmonic cusps
(Fig. 5E, F, and J). In contrast, the mitral valve retained its full
complement of EMT-derived cells (Fig. 5G and H). At E14.5, when
the semilunar valve defects ﬁrst became evident, a similar de-
crease in the number of EMT-derived cells was observed in the leftcusp of Nfatc1Cre;Brg1F/F pulmonic valves (mean 33.3%; Po0.04)
(Fig. 5C, D, and I). A comparable trend of reduced EMT-derived
cells likewise was seen in the right cusp. Given Nfatc1Cre;Brg1F/F
SLVs were of normal volume and cell number, the change in the
ratio of mesenchyme of different origins suggested non-EMT de-
rived mesenchyme expanded to replace the scarce EMT-derived
population.
EMT-derived cells of Nfatc1Cre;Brg1F/F SLVs could be reduced
due to a change in their net growth rate and/or deﬁcient EMT
when the cells were ﬁrst generated. To distinguish between these
possibilities, we examined proliferation rates by EdU incorporation
in EMT-lineage traced wildtype and Nfatc1Cre;Brg1F/F embryos.
Residual EMT-derived mesenchyme and endocardial cells pro-
liferated normally (Fig. 5K–M). In contrast, we observed a nearly
two-fold increase in EdU-incorporated non-Nfatc1Cre-lineage-la-
beled mesenchymal cells (Fig. 5M). Therefore, this specialized
cushion mesenchyme, likely of NCC and dOFT cushion origins,
proliferated to compensate for the deﬁcient EMT-derived pool.
Therefore, Brg1 is not inherently required in cushion mesenchyme
for cell growth or survival and origins of the semilunar valve de-
fects in Nfatc1Cre;Brg1F/F embryos likely rest earlier in outﬂow tract
development when EMT-derived cells are generated.
3.5. Semilunar valve defects originate from deﬁcient pOFT EMT
To determine if outﬂow tract EMT was disrupted in Nfatc1Cre;
Brg1F/F embryos, we examined cushion development at E10.5, less
than 24 h after EMT onset. The pOFT, but not the NCC-populated
dOFT cushions of Nfatc1Cre;Brg1F/F embryos contained approxi-
mately half the normal number of mesenchymal cells (po0.022)
(Fig. 6A, B, and E). As expected, the AVC cushions were normal
(Fig. 6C–E). We used the Rosa26RmTmG reporter line to conﬁrm the
deﬁcient pOFT mesenchyme in E10.5 Nfatc1Cre;Brg1F/F embryos
represented a loss of EMT-derived cells (Fig. 6F–G). A reduced
pOFT with fewer lineage-traced EMT-derived cells persisted at
E11.5 in endocardial Brg1-deﬁcient embryos (Fig. 6H–K). We fur-
ther explored a potential primary pOFT EMT defect in Nfatc1Cre;
Brg1F/F embryos using collagen gel explant assays (Runyan and
Markwald, 1983) and a Nfatc1Cre-driven lineage tracing approach
to brightly labeled EMT-derived cell nuclei with GFP. E10.0
Nfatc1Cre;Brg1F/F;Rosa26RrtTA;TRE:H2B-GFP OFT cushion explants
produced signiﬁcantly fewer GFPþ mesenchymal cells (Po1.0E-4)
(Fig. 6L–N). These results conﬁrmed that endocardial deletion of
Brg1 driven by Nfatc1Cre produced a modest EMT defect in the
pOFT but not AVC cushions.
We questioned whether the isolated pOFT EMT defect in
Nfatc1Cre;Brg1F/F embryos represented a speciﬁc BAF complex role
in pOFT endocardium, or if the induction of Cre activity in the
Nfatc1Cre line was too late to remove Brg1 in AVC endocardial cells
prior to EMT. Supporting this latter possibility, EMT occurs earlier
in the AVC than pOFT (Camenisch et al., 2002). Further, Nfatc1Cre;
Brg1F/F embryos did not exhibit a widespread loss of endocardial
Brg1 protein until E10.5 (Figs. S8 and S9). To achieve an earlier
deletion, we used Tie2:Cre with the ﬂoxed Brg1 alleles to remove
endocardial Brg1 by E9.5 (Stankunas et al., 2008). E9.75 Tie2:Cre;
Brg1F/Fembryos displayed a near complete absence of EMT in both
the pOFT and AVC cushions (Fig. 6O–R). Therefore, endocardial BAF
complex-mediated chromatin remodeling is required for both AVC
and pOFT EMT. The serendipitous timing of Brg1 deletion at the
onset of EMT accounts for the unique and partial pOFT EMT deﬁ-
ciency seen in Nfatc1Cre;Brg1F/F embryos.
To assess potential ongoing endocardial roles for Brg1, we used
an additional Cre line, Nfatc1enh:Cre, to delete ﬂoxed Brg1 in
cushion endocardial cells that undergo minimal or no EMT (Wu
et al., 2011). Lineage tracing experiments using Rosa26RmTmG
conﬁrmed that Nfatc1enh:Cre was active only in cushion
Fig. 5. A depleted pool of EMT-derived mesenchyme in endocardial Brg1-deﬁcient semilunar valves is replaced by increased proliferation of other mesenchymal lineage(s).
(A–H) Sections of Nfatc1Cre;Brg1F/þ;R26RmTmG and Nfatc1Cre;Brg1F/F;R26RmTmG embryos (pulmonic valve except mitral valve in (G and H); genotype and age as indicated)
immunostained for GFP (Nfatc1Cre-lineage derived cells, green) and nuclei (Hoechst-stained, purple). Arrowheads indicate EMT-derived mesenchymal cells at the pulmonic
valve cusp base near the cushion-myocardium boundary. (I and J) Quantiﬁcation of the relative contribution of Nfatc1Cre-lineage pulmonic valve mesenchyme in control
(Brg1F/þ) and endocardial Brg1-deﬁcient embryos (Brg1F/F) at E14.5 (I) and E16.5 (J). Left (L-PV) and right (R-PV) cusps are scored separately. The percentile fraction of
Nfatc1Cre-lineage mesenchyme for each embryo is normalized to the mean of corresponding littermate wildtype samples. The mean absolute percentage of labeled and
unlabeled cells is shown within individual bars of the chart (n¼5). (K–L) E14.5 wildtype (Nfatc1Cre;Brg1F/þ;R26RmTmG) (K) and Nfatc1Cre;Brg1F/F;R26RmTmG (L) pulmonic valve
sections stained with GFP (Nfatc1Cre-lineage, green), EdU-incorporating proliferating cells (red), and Hoechst (nuclei, blue). White arrows denote EdUþ , non-Nfatc1Cre-lineage
mesenchymal cells. (M) Quantitation of the proliferation rate of Nfatc1Cre- and other-lineage pulmonic valve mesenchyme in E14.5 control and Nfatc1Cre;Brg1F/F embryos. The
mean absolute fraction of EdU-incorporated cells for each condition is shown. For all graphs, error bars show one standard deviation of the mean. Asterisks indicate a
signiﬁcant difference (Po0.05, two-tailed Student's t-tests). NS: not signiﬁcant; GFPþ: Nfatc1Cre-lineage labeled mesenchyme; Non-LL: non-Nfatc1Cre-lineage labeled me-
senchyme. Scale bars: 100 μm.
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D). Nfatc1enh:Cre;Brg1F/F embryos exhibited no change in semi-
lunar valve morphology at E14.5 or E16.5 (Fig. S10E–L). The ab-
sence of major post-EMT roles for Brg1 in either endocardium or
cushion mesenchyme suggests that pOFT EMT is the disrupted
process that “triggers” semilunar valve defects in Nfatc1Cre;Brg1F/F
embryos. The ultimate manifestation of disorganized ECM and
poorly patterned valves thus represents a progression towards a
disease-like state, driven by imperfect compensation by non-EMTderived and functionally distinct mesenchymal cells.3.6. Transcriptional proﬁling of Brg1-deﬁcient cardiac cushions re-
veals novel regulators
We sought to characterize misexpressed transcripts in
Nfatc1Cre;Brg1F/F embryos that could characterize and/or promote
the progression of their EMT-deﬁcient SLVs into a diseased state.
None amongst a select group of semilunar valve disease-
B.N. Akerberg et al. / Developmental Biology 407 (2015) 158–172 167associated transcripts were misexpressed by quantitative qRT-PCR
at E14.5 (Fig. S11). Therefore, we used RNA-Seq to identify differ-
ences between the E14.5 SLV transcriptomes of wildtype and
Nfatc1Cre;Brg1F/F embryos. We identiﬁed 43 differentiallyexpressed genes (DEGs) (22 increased, 21 decreased; Table S1) and
selected seven for further study (see Supplemental materials and
methods). We used quantitative RT-PCR on additional sets of dis-
sected tissue to conﬁrm both up-regulated (Nptx1, Clec7a and
Fig. 7. RNA-seq identiﬁes novel semilunar valve expressed transcripts misexpressed in endocardial lineage Brg1-deﬁcient valves.
(A) Select differentially expressed genes (DEGs) identiﬁed from an RNA-seq analysis comparing two paired samples of wildtype and Nfatc1Cre;Brg1F/F dissected E14.5 heart
valve tissue. 26 DEGs (green-upregulated; red-downregulated) are listed with fold change and false discovery rate (FDR). Transcripts of particular interest are highlighted. (B
and C) Quantitative RT-PCR expression studies of the highlighted DEGs in (A) E14.5 (B) and E16.5 (C) valves. Bar heights represent the log-base-2 fold change in gene
expression (linear mean fold change value indicated below bars) between Nfatc1Cre;Brg1F/F and wildtype tissue. Error bars represent one standard deviation with the
additional error bars centered along the x-axis showing the variation between wildtype samples. Double asterisks indicate a signiﬁcant difference including a Bonferroni
correction (one-tailed Student's t-test, n¼7, Po0.007); single asterisk indicates a Po0.05. (D–K) RNA in situ hybridizations for indicated transcripts on pulmonic valve
sections of E13.5 wildtype or littermate Nfatc1Cre;Brg1F/F embryos. Arrowheads highlight areas of highest transcript expression. Scale bar: 100 μm.
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genes were signiﬁcantly misexpressed at E14.5. At E16.5, Clec7a,
Cthrc1, and Nptx1 remained upregulated, suggesting they deﬁne a
progressively worsening disease-like state (Fig. 7B and C). Con-
versely, Col23a1, Enpp2 and Smoc1 transcripts were no longer
decreased at E16.5, indicating these genes were transiently mis-
expressed in endocardial Brg1-deﬁcient embryos at the onset of
overt semilunar valve defects.
To characterize the cell type-speciﬁc expression of these po-
tential regulators of SLV development and disease, we performed
in situ hybridizations on E13.5 wildtype and Nfatc1Cre;Brg1F/F em-
bryos. Nptx1, a member of the neuronal pentraxin family (Omeis
et al., 1996; Boles et al., 2014) was expressed in the most distal
endocardial cells of the pulmonic valve and at notably higher le-
vels in endocardial Brg1-deﬁcient embryos (Fig. 7D and E). Nptx1
expression never was observed in the mitral valve, suggesting that
Nptx1 is an OFT endocardium-speciﬁc transcript (Fig. S12A–D). In
contrast, the collagen triple helix repeat containing 1, Cthrc1Fig. 6. Reduced EMT-derived semilunar valve mesenchyme in Nfatc1Cre;Brg1F/F embryos origin
(A–D) H&E stained sagittal sections of E10.5 wildtype and Nfatc1Cre;Brg1F/F embryos. The pro
cushions (C and D) are shown. Arrowheads indicate pOFT mesenchyme. (E) Scoring of mesen
embryos. Each point shows one embryo and all values are normalized to the mean of littermate
and G; J and K)Wideﬁeld ﬂuorescence images of OFT regions from transverse sectioned E10.5 (F
Nfatc1Cre-lineage tracing, green) and Nfatc1 (endocardium, red). Nuclei are stained with Hoechst
K) embryos are shown. (H and I) H&E stained sagittal sections of E11.5 wildtype and Nfatc1
ﬂuorescence overlaid images of collagen gel OFT explants from E10.0 control and Nfatc1Cre;Brg1F
transgenes and explants are treated with doxycycline to induce H2B-GFP expression (to label N
mesenchymal cells. (N) Quantiﬁcation of Nfatc1Cre-lineage mesenchymal cells migrating throug
the mean of littermate wildtype explants. The asterisk indicates statistical signiﬁcance (two-tai
sections showing AVC (O and P) and pOFT (Q and R) cushions of wildtype and Tie2:Cre;Brg1F/F E
of endocardial-derived cushion mesenchymal cells. Arrows in (Q and R) show neural crest-ori(Pyagay et al., 2005), protein was found only in mesenchymal cells
at the very base of the cusps where cushion-derived tissue meets
adjacent myocardium. As expected, cushion mesenchyme Cthrc1
levels were higher in Nfatc1Cre;Brg1F/F embryos (Fig. 7F and G).
Further, Cthrc1 was increased in aortic valve mesenchyme and
became ectopically expressed in both valve and ventricular en-
docardium (Fig. S12E–J). Enpp2, a secreted phospholipase required
for lysophosphatidic acid production (Tokumura et al., 2002;
Umezu-Goto et al., 2002), and Irf6, an interferon-responsive factor
(Kondo et al., 2002), were both speciﬁcally expressed in en-
docardial cells on the arterial side of wildtype pulmonic valves.
Enpp2 and Irf6 were largely absent in the endocardium from
Nfatc1Cre;Brg1F/F semilunar valves (Fig. 7H–K, Fig. S12K, M, O, and
R). In contrast, pulmonic arterial endothelial expression of Irf6 was
unchanged (Fig. S12Q and T). Given their misexpression in en-
docardial and/or EMT-derived cells, these four DEGs could re-
present directly repressed (Nptx1, Cthrc1) or activated (Enpp2, Irf6)
targets of BAF complex chromatin remodeling. Further studies areates from deﬁcient pOFT EMT, a process that generally requires Brg1 function.
ximal (pOFT) and distal (dOFT) outﬂow tract (A and B) and atrioventricular canal (AVC)
chymal cells populating the pOFT or AVC cushions in E10.5 wildtype and Nfatc1Cre;Brg1F/F
wildtype samples. Asterisk denotes a signiﬁcant difference (two-tailed Student's t-tests). (F
and G) or sagittal sectioned E11.5 (J and K) embryos. Tissue is immunostained for GFP (for
(blue). Control (Nfatc1Cre;Brg1F/þ;R26RmTmG; F and J) and Nfatc1Cre;Brg1F/F;R26RmTmG (G and
Cre;Brg1F/F embryos. Arrowheads indicate pOFT mesenchyme. (L and M) Brightﬁeld and
/F embryos (24 h post-dissection). All embryos additionally carry R26RrtTA and TRE:H2B-GFP
fatc1Cre-lineage mesenchymal cells, green). White arrowheads denote EMT-derived (GFPþ)
h the collagen matrix. Each point represents one explanted OFT. Values are normalized to
led Student's t-test). (O–R) Endocardial Brg1 is required for all cushion EMT. H&E stained
9.75 littermate embryos. Arrowheads denote either the presence or a depleted/absent pool
gin mesenchyme within the dOFT cushions. Scale bars: 100 μm.
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disease and/or broader utility as markers of SLV disease
progression.4. Discussion
4.1. Endocardial Brg1 deletion establishes a model of semilunar valve
disease with origins in deﬁcient EMT
We describe a new mouse model of semilunar valve disease
caused by deletion of Brg1 in the endocardial lineage. Nfatc1Cre;
Brg1F/F mice develop thickened, blunted, and occasionally fused
valve cusps that become myxomatous in surviving adults. We map
the origins of these phenotypes to disrupted pOFT EMT, one of the
earliest steps in valve development. OFT mesenchyme of other
origins, likely cardiac neural crest, compensates for the deﬁcient
EMT-derived cells by relatively increased proliferation but is in-
competent to fully generate the complex 3-dimensionally pat-
terned interstitium of a tricuspid semilunar valve. As such, the
cellular and extracellular changes that characterize the abnormal
semilunar valves represent secondary responses to a disrupted
system, rather than reﬂecting later developmental or physiologic
roles of Brg1.
4.2. Chromatin remodeling contributes to endocardial cushion EMT
Early deletion of ﬂoxed Brg1 in all endocardial cells using the
Tie2:Cre driver disrupted EMT in both the AVC and pOFT cushions.
These results establish chromatin remodeling as a component of
the transcriptional networks that promote EMT. Endocardial Brg1
deletion does not have a signiﬁcant effect on endocardial cell
death or proliferation (Stankunas et al., 2008), suggesting that
cushion endocardial BAF complexes have a relatively speciﬁc
transcriptional role in EMT. A simple explanation is that the BAF
complex has a common chromatin remodeling role in all EMT
processes, whether in the endocardial cushions or other devel-
opmental/disease situations. Consistent with this possibility, the
Baf60c subunit of the BAF complex is required for EMT in cancer
cell lines (Jordan et al., 2013) and Brg1 interacts with the Zeb1
transcription factor to promote a terminal step in the mesenchy-
mal transition of MCF7 cells (Sánchez-Tilló et al., 2010). Alter-
natively, effectors of upstream EMT-inducing signaling pathways,
such as TGF-beta or Notch signaling, may recruit BAF complex
activity to induce EMT. In support of these possibilities, both the
Smad2/3 effectors of TGF-beta signaling and activated Notch1,
each of which has been implicated in both AVC and pOFT EMT,
cooperate with the BAF complex and/or induce chromatin re-
modeling in other circumstances (Takeuchi et al., 2007; Xi et al.,
2008).
4.3. The semilunar valve interstitium is organized into regions en-
riched with mesenchyme of different origins
Multiple lineage tracing studies suggest a complex patterning
of multi-origin mesenchymal populations within semilunar valves
(Jiang et al., 2000; de Lange et al., 2004; Nakamura et al., 2006;
Jain et al., 2011; Phillips et al., 2013). Our simultaneous study of the
localization of valve ECM components with Nfatc1-based lineage
tracing indicates that the patterned ECM composition of semilunar
valves is conferred by the regulated organization of mesenchymal
cells with differential competency to produce ECM proteins. For
example, EMT-derived cells likely produce the Tnc-enriched base
of the left semilunar valve cusps that is depleted in Nfatc1Cre;Brg1F/
F embryos. As a corollary, the increased Postn seen in Nfatc1Cre;
Brg1F/F embryos could reﬂect an expanded non-EMT origin (likelyneural crest-derived) mesenchyme that continues to fulﬁll its
normal role of secreting Postn. This general concept of semilunar
valve patterning provides a framework to understand when and
how valve regulators function and comprehend how various me-
chanisms can generate valve defects.
4.4. Interpreting mouse models of semilunar valve disease
A number of other mouse models exhibit either bicuspid aortic
valve and/or semilunar valve disease-like phenotypes. When bi-
cuspid, the aortic valves of Nfatc1Cre;Brg1F/F embryos display either
a RCC–NCC or, more frequently, what in humans is the rarest LCC–
NCC subtype (Fernandes et al., 2004; Fernández et al., 2009; Kang
et al., 2013). Grewal et al. proposed that the “type I” subtype
showing fusions between RCC–LCC cusps is caused by a deﬁciency
of NCCs (Jain et al., 2011; Phillips et al., 2013; Grewal et al., 2014).
In contrast, “type II” fusions (RCC–NCC) are suggested to be of
second heart ﬁeld (SHF) origin, which could encompass pOFT EMT
defects given the outﬂow tract's SHF origins. Consistent with this
idea, the Nos3-deﬁcient mouse model of BAV develops RCC–NCC
fusions and may, like the Brg1-deﬁcient model, originate from
defective EMT (Fernández et al., 2009). Whether a RCC–NCC or
LCC–NCC fusion occurs could reﬂect the severity of the EMT dis-
ruption, consistent with the variable Brg1 deletion in Nfatc1Cre;
Brg1F/F embryos.
Could other mouse models of thickened and disorganized
semilunar valves also have origins in pOFT EMT defects? Sup-
porting this hypothesis, several other models disrupt known or
potential EMT regulators, including the TGF-β effector Smad2
(combined with Adamts5), TGF-β family receptors (Alk2), Gata-
family transcription factors (Gata5), Notch signaling, and BMP
signaling (BMP4) (Camenisch et al., 2002; Timmerman et al., 2004;
Ma et al., 2005; Wang et al., 2005; McCulley et al., 2008; Laforest
et al., 2011; Moskowitz et al., 2011; Thomas et al., 2012; Bosse
et al., 2013; Dupuis et al., 2013). Testing this idea would require
directly examining these mice for pOFT EMT defects as well as
monitoring their valves for a deﬁcient Tnc-expressing base region,
as observed in the endocardial Brg1-deﬁcient model. Another set
of models, for instance Cxcr7KO, EgfrKO;Ptpnllþ /- and HbegfKO have
clear hyperplastic semilunar valve cusps (Chen et al., 2000; Jack-
son et al., 2003; Yu et al., 2011), which we did not observe in
Nfatc1Cre;Brg1F/F embryos by EdU incorporation and cusp volume
measurements. We postulate that this manifestation of a semi-
lunar valve defect likely originates in misregulated proliferative
signals rather than deﬁcient EMT. However, our combined EdU
incorporation and lineage tracing of Nfatc1Cre;Brg1F/F valves does
show how a subset population of semilunar valve mesenchyme
can have an increased proliferative rate even while overall me-
senchyme proliferation is unchanged. In endocardial Brg1-deﬁ-
cient mice, this effect is non-autonomous, with non-EMT derived
mesenchyme increasing their relative rate of proliferation to
compensate for the deﬁcient EMT-derived cells. This observation
also supports the idea that different valve mesenchymal popula-
tions communicate to modulate each other's growth and organi-
zation (Jain et al., 2011; Wu et al., 2011). By extension, neural crest
(or other origin) mesenchyme could also be genetically perturbed
in semilunar valve disease, as indicated by Rho kinase-inhibited and
Pax3-deﬁcient models (Jain et al., 2011; Phillips et al., 2013).
4.5. RNA-seq of the endocardial Brg1-deﬁcient valves uncovers po-
tential novel regulators of semilunar valve development and disease
Our transcriptomics study of E14.5 Nfatc1Cre;Brg1F/F valve re-
gions identiﬁed a number of such potential novel regulators of
valve development and/or disease biomarkers. For example, we
found misexpressed negative regulators of both BMP signaling
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Colas et al., 2012), two pathways that can be aberrantly active in
mesenchyme of developmentally abnormal valves (reviewed in
Conway et al., 2011). Our subsequent RNA ISH analysis revealed
that several of the misexpressed genes had highly speciﬁc and
unique expression patterns, showing the high degree of cellular
specialization within semilunar valves. For example, Nptx1 was
expressed only in distal tip endocardium of both semilunar valves.
Similarly, Enpp2, and Irf6 also are normally expressed in subsets of
endocardial cells. In contrast, Cthrc1 transcripts were restricted to
mesenchyme at the base of the semilunar valve. Given their al-
tered expression in endocardial or possible EMT-derived cells
(Cthrc1) of Nfatc1Cre;Brg1F/F valves, each of these genes may be a
direct target of BAF complex activation or repression. Indeed, Brg1
binds in the 5′ region of both Irf6 and Nptx1 genes by ChIP-Seq
studies of E11.5 hearts (Li et al., 2013).
4.6. Endocardial Brg1-deﬁcient model of semilunar valve disease
distinguishes between the origins and progression of semilunar valve
disease
Our interpretation of the valve defects in Nfatc1Cre;Brg1F/F em-
bryos provides an explanation for how semilunar valve disease,
including thickened and fused cusps, could commonly originate in
a sensitive EMT process of early valvulogenesis. Disease progres-
sion then represents the “best effort” of robust developmental
networks to produce and maintain a functional valve. As such, a
genetic understanding of inherited semilunar valve disease may
frequently reﬂect EMT mechanisms, while efforts to ther-
apeutically attenuate disease progression may merit focusing on
manipulating compensating cell lineages and/or their ECM pro-
ducts. For the former goal, mutations in BAF component genes
themselves are unlikely to be causes of aortic valve disease given
the pleiotropic roles of BAF complex driven chromatin remodeling.
However, interacting transcription factors and target genes of BAF-
direct chromatin regulation during EMT would represent attrac-
tive candidate disease genes. For the latter goal, our RNA-seq
analysis of progressively worsening valves in endocardial Brg1-
deﬁcient mice has identiﬁed new candidate regulators with highly
speciﬁc expression patterns that may characterize or even drive
progression of an anatomically abnormal valve into a disease state.5. Author Contributions
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